Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

The platform, which includes the new form factor CGM and the Simplera Sync sensor, is designed for integration with Medtronic ...

MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating ...